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Shope fibroma virus (SFV) N1R gene encodes a RING finger protein that localizes to virus factories within the cytoplasm
of infected cells. Altered proteins, with deletions and site-specific mutations, were transiently expressed in vaccinia
virus-infected cells to discern regions of the protein that are required for localization. We have determined that at least part
of the RING finger region is necessary for localization but that the RING motif alone is not sufficient. A chimeric protein,
however, in which the RING finger region of the herpes simplex virus-1 ICP0 protein replaces the SFV N1R RING motif does
localize to virus factories. A region of five highly conserved amino acids at the amino terminus of SFV N1R is also critical
for localization. We report that the SFV N1R protein binds double- and single-stranded DNA, suggesting a mechanism for
localization, and that overexpression of this protein in vaccinia virus-infected cells reduces apoptosis-associated fragmen-
tation of nuclear DNA. © 1998 Academic Press
INTRODUCTION
Poxviruses are large, complex, and relatively autono-
mous eukaryotic double-stranded (ds)DNA viruses that
are unusual because they complete their replication cy-
cle within the cytoplasm of infected cells (Moss, 1996).
On infection, a virus factory is established in the cyto-
plasm, often appearing close to the nuclear membrane,
and represents the site of viral transcription and DNA
replication. Electron and confocal microscopy has eluci-
dated some of the steps in poxvirus maturation, but the
process is still not well understood at the molecular level
(Sodeik et al., 1993; VanSlyke and Hruby, 1994). The
prototypic poxvirus, vaccinia virus (VV), has a genome of
191 kb and encodes ;200 proteins (Goebel et al., 1990;
Johnson et al., 1993). Poxviruses are ubiquitous, infecting
mammals, birds, reptiles, and invertebrates, although
after the eradication of smallpox [variola virus (VAR)], the
only widespread human pathogen is molluscum conta-
giosum virus (MCV) (Porter and Archard, 1994).
There appears to be a minimum set of poxvirus genes
that are required for viral transcription, genome replica-
tion, and assembly of progeny virions. These conserved
genes are clustered within the central region of the linear
genome. A second group of viral genes are not essential
for growth in vitro but are important for the replication of
the viruses in their natural hosts. A number of these have
been shown to effect host range, tissue specificity, and
virulence of poxviruses; examples include the secreted
cytokine binding proteins (Smith et al., 1991; Upton et al.,
1992; Spriggs et al., 1992; Spriggs, 1994), the epidermal
growth factor-like protein (Opgenorth et al., 1992), and
several of the poxviral serpins (Macen et al., 1993;
Thompson et al., 1993; Brooks et al., 1995). Approxi-
mately 60 of the nonessential VV genes are absent from
the distantly related MCV, which has a similar number of
genes that are apparently unique to MCV (Senkevich et
al., 1996). The examination of such genes and their gene
products can provide valuable information about the an-
tiviral response of the host and of the immune system in
general.
The focus of this report is another member of this
group of nonessential poxvirus virulence proteins. The
product of the Shope fibroma virus (SFV) gene N1R has
been previously shown to be a 28-kDa protein that lo-
calizes to the virus factory and binds zinc, presumably
due to the presence of a RING finger motif (C3HC4) at its
carboxyl terminus (Upton et al., 1994). The complete
homolog of this gene is present in a number of other
poxviruses, including myxoma virus (MYX), ectromelia
virus (EV) (Senkevich et al., 1994), VAR, and VV strain
IHD-W, but it is absent from the VV strain Copenhagen
and is truncated in VV strain WR (Upton et al., 1994). It is
interesting that inactivation of the gene encoding the EV
homolog, p28, had a large effect on the virulence of this
virus in mice, its natural host (Senkevich et al., 1994).
Mice infected through the footpad with wild-type EV (5
pfu) showed a uniform mortality with a mean day of death
of 9.7 days p.i., whereas all mice infected with the p28
mutant EV survived the challenges (Senkevich et al.,
1994). The expression of p28 is required for replication of
EV in murine resident peritoneal macrophages in vitro
(Senkevich et al., 1995), and it was proposed that this
attenuation of EV pathogenicity was due to failure of the
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virus to replicate in macrophages at successive steps in
its spread from the skin to target organs.
The RING finger motif is a conserved cysteine-rich
amino acid sequence that has been found in .80
proteins of diverse evolutionary origin (Saurin et al.,
1996; Borden and Freemont, 1996). The RING finger
motif has been defined as C-x(2)-C-x(9–39)-C-x(1–3)-
H-x(2–3)-C-x(2)-C-x(4–48)-C-x(2)-C (PROSITE: PS00518,
PDOC00449) and is unusual because of the zinc liga-
tion scheme (a cross-brace) in which the first pair of
cysteines coordinate a zinc atom with the third pair
and a second zinc atom is coordinated by a cysteine
and histidine (second pair) and the fourth pair of cys-
teines (Everett et al., 1993; Schwabe and Klug, 1994;
Borden et al., 1995). The RING finger motif has been
found in proteins that function in oncogenesis, devel-
opment, signal transduction, and apoptosis, but there
is little evidence of its specific role in these proteins
(Freemont, 1993; Borden and Freemont, 1996).
We used deletion and site-specific mutants of the SFV
N1R protein to further characterize requirements for lo-
calization to the virus factories and zinc binding. Regions
of the RING finger motif and five amino acids close to the
amino terminus of the protein were found to be critical for
localization. In addition, we have shown that the N1R
protein binds DNA cellulose and reduces apoptosis in
VV-infected cells.
RESULTS
Carboxyl-terminal deletion analysis of the SFV N1R
RING motif
To determine the role of the RING motif in the local-
ization of N1R to virus factories, modified N1R proteins
with carboxyl-terminal truncations (Fig. 1) were tran-
siently expressed in VV-infected cells. The vectors were
based on pMSN1 (Upton et al., 1994), which uses the
strong late promoter of pMJ601 (Davison and Moss,
1990). Localization of the modified proteins was deter-
mined by immunofluorescence microscopy. Deletions
ZD1, ZD2, ZD3, and ZD4, which remove progressively
more of the carboxyl-terminal portion of N1R up to and
including the third distal cysteine of the RING motif, had
little or no effect on the localization of N1R to the facto-
ries (Fig. 2: ZD1, ZD2, and ZD3 not shown). Deletions ZD1
and ZD2 affect only the last pair of coordinating cys-
teines, but the third distal cysteine is predicted to be
involved in coordinating the first zinc atom with the first
cysteine pair. The larger deletion, ZD5, which includes
the fourth distal cysteine abolished localization to the
virus factory (Fig. 2c); thus, the small difference between
deletions ZD4 and ZD5 delineates a region of the protein
that is required to permit normal localization to virus
factories. Each of the mutants created here and others in
the following experiments were shown to be expressed
at levels comparable to normal N1R and to be the correct
size by Western blots of extracts of transfected VV-
infected cells (Fig. 3).
In an attempt to correlate localization to virus factories
with zinc binding, we tested the deleted proteins in a zinc
blot (Fig. 4). All of the proteins, including deletion ZD5,
which failed to localize to the virus factory, bound zinc in
this assay. Because deletion ZD5 removes both the third
and fourth pairs of cysteines, binding of zinc at both sites
should be blocked if the SFV N1R is folded in a cross-brace
structure (Everett et al., 1993; Borden et al., 1995; Saurin et
al., 1996; Borden and Freemont, 1996). Although this result
FIG. 1. SFV N1R protein modifications. The complete amino acid sequence is shown for the SFV N1R protein. Carboxyl-terminal deletions are
indicated by the black bars (ZD1–5, respectively). Internal deletions (boxed) of amino acids 24–28 and 45–95, the end of the amino-terminal deletion
of 154 amino acids (right arrow), and positions of site specific mutations (vertical arrows) are indicated. Shown above the SFV sequence are the amino
acid sequences of (1) the RING motif from HSV-1 used to create the SFV-HSV fusion protein and (2) the RING motif from EHV.
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suggests that the cross-brace is not used by SFV N1R, the
zinc blot assay relies on the renaturation of protein after
blotting from an SDS-polyacrylamide gel, and it is therefore
possible that the observed zinc binding results from an
aberrant folding of the remaining portion of the RING motif
region, which still contains three cysteines and a histidine.
Molecular modeling (not shown) indicates a cross-brace
structure for the poxvirus RING motif is possible, but deter-
mination of its structure by NMR or crystallography may be
required to resolve this issue.
Effect of site-specific mutations on localization of the
SFV N1R protein
Because carboxyl-terminal deletions up to the third
distal cysteine did not affect localization, we made two
single-amino-acid changes and one two-amino-acid
change at noncysteine positions conserved between the
SFV and VV sequences in the central part of the SFV N1R
RING motif. Plasmids N1R-mFG190/191LR, N1R-mL193N,
and N1R-mI202N replace the following amino acids in
the SFV N1R protein: Phe190/Gly191 with leucine/
arginine, Leu193 with asparagine, and Ile202 with aspar-
agine, respectively. After transfection into VV-infected
cells, these mutant proteins localized to virus factories
(Fig. 2f), indicating that although these residues are con-
served between SFV and VV, these substitutions are
compatible with localization. These results prompted us
FIG. 2. Localization of SFV N1R protein in VV-infected cells shown by mAb H1119 and confocal microscopy. The proteins expressed from the
transfected vectors are as follows: (a) wild-type SFV N1R, (b) N1R-ZD4, (c) N1R-ZD5, (d) N1R-HSV fusion, (e) N1R-d24–28, (f) N1R-mL193N.
FIG. 3. Transient expression of SFV N1R mutant proteins in VV-infected
BGMK cells. (Lanes) 1, SFV N1R (wild type); 2, N1R-ZD1; 3, N1R-ZD2; 4,
N1R-ZD3; 5, N1R-ZD4; 6, N1R-ZD5; 7, N1R-ZD8; 8, N1R-mFG190/191LR; 9,
N1R-mL193N; 10, N1R-mI202N; 11, N1R-ZD6; 12, N1R-ZD7; 13, N1R-HSV;
M, standard proteins (and bars), 32.5, 25, and 16.5 kDa.
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to question whether other regions of the N1R protein
outside of the RING motif were directly involved in local-
ization to virus factories and whether N1R RING motif
could be replaced by another from a nonpoxvirus protein.
Deletion of the amino-terminal 154 amino acids of SFV
N1R (slightly more than half of the protein; Fig. 1) blocked
localization, demonstrating that the RING motif region is
not sufficient for association with the virus factory (data
not shown). Similarly, deletion of amino acids 45–95 from
SFV N1R (Fig. 1) resulted in loss of virus factory local-
ization (data not shown). In an attempt to delineate a
smaller region of the amino-terminal region of SFV N1R
that might be involved with localization, we examined the
alignment of the SFV and VV N1R protein homologs
(Upton et al., 1994). There is only 28% amino acid identity
between these proteins with the greatest similarity at the
carboxyl terminus, in the region of the RING motif. There
is, however, one block of five absolutely conserved
amino acids close to the amino terminus of SFV N1R
(residues 24–28; Fig. 1). This sequence, Tyr-Ile-Asn-Ile-
Thr, was deleted from SFV N1R by site-specific mutagen-
esis in plasmid N1R-d6. The deletion of this small region
prevented the SFV N1R protein from localizing to the
virus factors in VV-transfected cells (Fig. 2e). Thus, fac-
tory localization requires a small region at the amino
terminus of the protein and part of the RING motif; how-
ever, it is not possible to determine whether this amino-
terminal region is critical for a binding event or whether
it is required for correct folding of the protein.
Although the RING motif has been observed in a great
variety of proteins, its function remains unknown. We set
out to test the hypothesis that these motif regions may
fulfill similar functions in these proteins by constructing a
chimeric gene to express a protein that had the N1R
RING motif replaced by the RING motif of herpes simplex
virus type-1 (HSV-1) immediate-early protein ICP0. Trans-
fection of this construct (N1R-HSV) into VV-infected cells
demonstrated that this chimeric protein did indeed local-
ize to discrete regions within infected cells (Fig. 2d).
Because ICP0 is a nuclear protein, we confirmed that the
site of localization was the virus factories outside the
nucleus by using Hoechst dye 33342 to stain both the
viral DNA and the host nuclear DNA (Fig. 5). Thus, the
HSV ICP0 RING motif can replace the SFV N1R RING
motif in supporting factory localization.
SFV N1R protein binds to both dsDNA and single-
stranded DNA cellulose
To differentiate whether the SFV N1R protein is local-
ized to the virus factory because of binding to viral DNA
or an affinity for another virus factory protein, we tested
its ability to bind to DNA cellulose columns. The recom-
binant virus VV-N1R was used to produce the SFV N1R
protein, all of which appears to localize to virus factories
when examined by immunofluorescence (data not
shown). Little soluble N1R protein was observed in ly-
sates of infected cells, but the protein was extracted
when 0.6 M NaCl was included in the buffer. Desalted
protein extracts were loaded onto dsDNA and single-
strand (ss)DNA columns and eluted with NaCl step gra-
dients. A Western blot showing SFV N1R protein binding
to and eluting from dsDNA (0.5–0.75 M NaCl) is shown in
Figure 6. A similar profile was seen for ssDNA (data not
shown). When 1 mM EDTA was included in the desalting
buffer, the protein did not bind to the dsDNA column,
suggesting that zinc and the structural integrity of the
RING motif region are required for DNA binding. It is
possible that SFV N1R protein localizes to the virosome
and binds DNA via an associated viral protein. This
appears unlikely, however, because the poxviral N1R
protein homologs, which are poorly conserved overall,
localize in cells infected by distantly related poxviruses.
For example, the SFV, MYX, and EV proteins localize in
VV-infected cells, and the VV, EV, and SFV proteins local-
ize in MYX-infected cells (data not shown).
Expression of SFV N1R protein delays apoptosis
in VV-infected cells
Apoptosis, often referred to as programmed cell death,
is a physiological process by which the cell actively
FIG. 4. Zinc binding by SFV N1R proteins with carboxyl-terminal
deletions. (Top) Coomassie blue-stained polyacrylamide gel of SFV
N1R proteins isolated as inclusion bodies expressed in E. coli. Bars
indicate (top to bottom) standards (alcohol dehydrogenase, 40 kDa;
carboxypeptidase A, 35 kDa; carbonic anhydrase, 29 kDa) and SFV N1R
protein. (Bottom) Autoradiogram of a zinc blot from a gel identical to
that shown in the top. (Lanes) 1, bacterial vector pET19b; 2, MYX N1R
homolog; 3, SFV N1R; 4, SFV N1R-ZD1; 5, SFV N1R-ZD2; 6, SFV NIR-
ZD3; 7, SFV N1R-ZD4; 8, SFV N1R-ZD5; 9, SFV N1R; 10, standard
proteins.
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participates in a cascade of biomolecular events that
result in the death and disposal of the cell. It is important
in development, in the regulation of cell numbers, and as
a defense mechanism to remove unwanted and poten-
tially dangerous cells, such as self-reactive lymphocytes,
tumor cells, and virus-infected cells (Nagata, 1997). We
decided to test the hypothesis that the SFV N1R protein
might be involved in blocking apoptosis induced by VV
because a number of cellular proteins with RING motifs
have key roles in regulation of apoptosis (Rothe et al.,
1994; Uren et al., 1996; Lee et al., 1997; Hu et al., 1994;
Thut et al., 1997; Devereaux et al., 1997) and inactivation
of the EV homolog (p28) significantly reduces virus viru-
lence (Senkevich et al., 1994). Apoptosis was measured
using a standard assay for the fragmentation of host
chromosomal DNA into small oligonucleosomes (Koyama
and Miwa, 1997). No DNA laddering was seen at 24 h,
but VV-infected BGMK cells showed significant laddering
by 48 h. In contrast, cells infected with a VV recombinant
expressing the SFV N1R protein (VV-N1R) showed little or
no laddering at this time or at 54 h (Fig. 7). The sensitivity
of this assay (Eastman, 1995; Gavrieli et al., 1992; Sal-
game et al., 1997), which uses ethidium bromide to visu-
alize DNA separated on agarose gels, is such that we
believe the majority of infected cells are undergoing
apoptosis and contributing to the observed signal. This
is supported by the data from an ELISA measuring cyto-
plasmic apoptotic nucleosomes. The assay, which is at
least 10-fold more sensitive than the laddering assay,
shows a similar absence of apoptosis at 24 h and inhi-
bition of nucleosome release by VV-N1R at 48 h. Apopto-
sis was induced in control uninfected cultures by treat-
ment with cycloheximide (200 mg/ml); microscopic in-
spection of these cells indicated that all cells had
undergone morphological changes. A lower cyclohexi-
mide concentration (30 mg/ml) has previously been
shown to induce apoptosis in .60% of HeLa cells (Kettle
et al., 1997). The extent of nucleosome release in the VV
infected cells at 48 h was comparable to that observed in
FIG. 5. The HSV-1 ICP0 RING motif can replace the SFV N1R RING motif for virosome localization. Vectors (A and B, SFV N1R; C and D, N1R-HSV)
were transfected into VV-infected cells, and localization was determined by immunofluorescence. (A and C) Protein detection by immunofluorescence.
(B and D) Identical fields visualized for DNA stained with bisbenzimide. p, Virus factories.
FIG. 6. Western blot showing binding of SFV N1R protein to dsDNA
cellulose. Buffer was 50 mM NaCl, 3 mM 2-mercaptoethanol, 10 mM
ZnCl2, 1 mM phenylmethylsulfonyl fluoride, 50 mM Tris (pH 8.0). (Lanes)
1, Protein extract loaded onto column; 2, molecular weight standards; 3,
recycled flowthrough; 4, wash, no NaCl; 5, 0.1 M NaCl; 6, 0.25 M NaCl;
7, 0.5 M NaCl; 8, 0.75 M NaCl; 9, 1.0 M NaCl; 10, 1.5 M NaCl. p, SFV N1R
protein. The band above the SFV N1R protein represents a host protein
that cross-reacts with mAb H1119.
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a cycloheximide-induced apoptotic culture (Fig. 7B).
Thus, the expression of SFV N1R protein in VV-infected
cells significantly reduced virus-induced apoptosis. In
similar assays, we also observed that EV-infected cells
did not produce apoptotic DNA ladders, even at 54 h p.i.
(data not shown). It will be interesting to determine
whether the EV p28 RING homolog is involved in produc-
ing this effect.
DISCUSSION
The SFV N1R RING finger protein and several other
poxvirus homologs are known to localize to the virus factory
in the cytoplasm of infected cells. We performed deletion
and mutational analysis of the SFV N1R RING finger gene
and expressed the mutant proteins transiently in VV-in-
fected cells to determine which regions of this protein are
required for localization to the virus factory. These experi-
ments have shown that part of the RING motif region is
required for localization but that a substantial portion could
be deleted with little or no effect. Another deletion mutant
demonstrated that the carboxyl-terminal half of the protein,
which contains the complete RING motif region, does not
localize to virus factories. In addition, we recognized a
five-amino-acid region at the amino terminus of the SFV
protein (amino acids 24–28) that is highly conserved among
the poxvirus homologs and have shown that it is essential
FIG. 7. Protection from apoptosis by expression of SFV N1R in VV-infected BGMK cells. (A) Ethidium bromide-stained agarose gel. (Lanes) 1 and
6, HindIII-digested lambda DNA; lanes 2, 7, and 11, mock infected; lanes 3, 8, and 12, mock infected, no serum; lanes 4, 9, and 13, VV-N1R infected;
lanes 5, 10, and 14, VV infected. Samples taken at 24 h, lanes 2–5; 48 h, lanes 7–10; 54 h, lanes 11–14. (B) Detection of apoptotic cytoplasmic
oligonucleosomes by ELISA. Duplicate samples were collected, and each was assayed in triplicate (ELISA).
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for virus factory localization. It is therefore apparent that the
RING motif is not solely responsible for localization, nor is
the entire motif required for this effect. This is consistent
with a growing body of evidence that suggests the RING
motif does not necessarily function as an independent
protein domain but rather may be part of a larger domain of
those proteins in which it is found (Maul and Everett, 1994;
Everett et al., 1995; Bellon et al., 1997; Clem and Miller,
1994). Thus, the structural similarity that the RING motifs
appear to share, as inferred by molecular modeling studies,
may not be predictive of common functionality. This idea is
supported by our result that showed the RING motif of
HSV-1 ICP0 could substitute for that of SFV N1R for virus
factory localization. Other motif switching experiments,
however, have not been as successful. The RING motif of
PML does not replace that of HSV-1 ICPO (Everett et al.
1995). It will be interesting to determine whether the SFV-
HSV-1 fusion we generated retains other characteristics of
the wild-type SFV N1R protein.
Although DNA binding has been reported for several
proteins containing RING motifs (Hiom and Gellert, 1997;
Gong et al., 1997; Bailly et al., 1997; Kanno et al., 1995), it
does not appear to be a common characteristic of this
group of proteins. Attempts to show DNA binding of the EV
p28 protein were inconclusive because of protein insolu-
bility problems (Senkevich et al., 1994, 1995). After initial
difficulties in solubilizing the SFV N1R from VV-N1R-infected
cells, we were able to show that this protein binds to both
dsDNA and ssDNA cellulose but only when EDTA was
omitted from the binding buffer. Two features, the broad
range of NaCl concentration over which the SFV N1R eluted
from DNA cellulose (0.5–0.75 M NaCl) and its molecular
weight, suggest that SFV N1R may be the homolog of a
previously described VV 28-kDa virus factory-associated
DNA-binding protein (designated FP14) (Nowakowski et al.,
1978). However, these experiments were reportedly per-
formed with VV strain WR, and we have shown that VV WR
produces a significantly truncated protein that does not
localize to the virus factory (Upton et al., 1994). Clarification
of this issue must await further experimentation. Studies
using the EV p28 mutant indicated that this gene product
was required for viral replication in peritoneal resident mac-
rophages because virus factories were not detected by
Hoechst dye staining (Senkevich et al., 1995). Thus, the
DNA-binding activity of this group of poxviral proteins may
be required only as an accessory factor for DNA replication
or transcription in certain cell types. Alternatively, these
proteins may serve to recruit a host protein to the virus
factory.
Self-destruction of virus-infected cells by induction of
apoptosis is an important host defense process, so it
should not be surprising that many viruses have evolved
mechanisms to avoid or delay its onset (Teodoro and
Branton, 1997). Poxviruses block apoptosis at several
distinct steps in the induction pathway. Well character-
ized examples include soluble tumor necrosis factor
(TNF) binding proteins that modulate activation of the
TNF receptor 1 apoptotic signaling pathway (Sedger and
McFadden, 1996) and the serpin encoded by crmA,
which inhibits cytotoxic T lymphocyte-mediated apopto-
sis (Fas and TNF induced) by blocking caspase activity
(Zhou et al., 1997). MCV possesses two genes (MC159l
and MC160l) that contain duplicated death effector do-
main motifs that are found in proteins in the Fas and TNF
signal transmission pathways (Senkevich et al., 1997).
Expression of MC159L has been shown to protect cells
from apoptosis induced by these ligands (Bertin et al.,
1997). Overexpression of SFV N1R gene in a recombinant
VV significantly reduced apoptosis of cells infected with
this virus compared with cells infected by wild-type VV,
suggesting that this protein may be involved in yet an-
other poxviral antiapoptotic process. At early times, in-
duction of apoptosis is expected to inhibit the accumu-
lation of infective virus progeny; at late times, it may
serve to interfere with the release and spread of the new
virus particles. Our observation is that the SFV N1R
protein reduces apoptosis at late times (after 24 h); thus,
it may serve to increase the spread of the virus infection
in an infected animal host.
A number of other proteins that possess RING motifs
have been shown to be involved in the regulation of
apoptosis. Baculoviruses encode an inhibitor of apopto-
sis (IAP) (Crook et al., 1993), and several eukaryotic
homologs have been recently cloned and sequenced
(Uren et al., 1996). The mammalian IAP homolog (MIH) B
has been shown to bind TNF receptor-associated factor
TRAF2 (Uren et al., 1996), which also contains a RING
motif (Rothe et al., 1994), suggesting that the IAPs may
interfere with signaling pathways required for apoptosis.
In this respect, a carboxyl-terminal RING motif truncation
mutant of MIH-B inhibits nuclear factor-kB induction by
TNF and enhances TNF killing (Chu et al., 1997). We have
performed immunoprecipitations with monoclonal anti-
body (mAb) H1119 (which can immunoprecipitate HSV-1
ICP27; S. Rice, personal communication) and VV-N1R-
infected cells to detect proteins that interaction with SFV
N1R, but we have been unable to immunoprecipitate SFV
N1R, although b-galactosidase, which is also expressed
by VV-N1R, immunoprecipitated under the conditions
tested (data not shown). It appears that the majority of
the SFV N1R protein bound tightly in the virus factories,
but this, however, does not exclude a role for this protein
in binding and possibly sequestering factors that are
involved in apoptosis signaling.
Previously, the lack of virulence of the EV p282 mutant
has been attributed to reduced replication in macro-
phages. Our observation that the SFV N1R protein, a
homolog of p28, blocks apoptosis suggests a second
function for this protein, which we have shown to localize
to the virus factory, possibly due to DNA binding. The
relationship between the role of SFV N1R in factory
localization and inhibition of apoptosis is presently un-
known, but it is not uncommon for viral gene products to
have more than one function. Interestingly, in this re-
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spect, the baculovirus p35 protein, a broad-spectrum
inhibitor of apoptosis, was also found to facilitate viral
replication (Hershberger et al., 1992, 1994). Clarification
of the role of these poxviral RING finger proteins in
blocking of apoptosis or inflammation is especially im-
portant because it may have implications for the design
of poxvirus-based vaccines.
MATERIALS AND METHODS
Cells and viruses
SFV (strain Kasza), VV (strains WR and IHD-W), and
BGMK cells were provided by Dr. G. McFadden. Viruses
and cells were grown at 37°C in Dulbecco’s modified
Eagle’s medium supplemented with 10% newborn bovine
serum (GIBCO BRL, Gaithersburg, Maryland), except
where indicated.
Antibodies and Western blotting
Mouse mAb H1119 (Goodwin Institute for Cancer Re-
search, Plantation, Florida) recognizes an epitope in a
12-amino-acid sequence of the HSV-1 ICP27 protein. The
gene sequence for this epitope is fused to the amino
terminus of the N1R gene in plasmid pMSN1, and trans-
fection of pMSN1 and constructed mutants to VV-in-
fected cells was performed as previously described (Up-
ton et al., 1994). Protein samples were separated on 12%
SDS-PAGE, transferred to PVDF membrane (Gelman Sci-
ences, Ann Arbor, Michigan), and blocked with 3% bovine
serum albumin in Tris-buffered saline overnight before
incubation with mAb H1119 (1:2000). Bound antibody was
detected by the Immun-Blot alkaline phosphatase assay
(BioRad Laboratories, Hercules, California).
Recombinant DNA procedures
Restriction enzymes were obtained from New England
Biolabs (Beverly, MA), unless otherwise stated. Plasmid
pMSN1 has been described previously and contains an
epitope tagged SFV N1R open reading frame under the
control of a strong synthetic poxvirus promoter (Upton et al.,
1994). Carboxyl-terminal deletion mutants of the SFV N1R
gene were constructed by polymerase chain reaction (PCR)
(Pfu DNA polymerase; Stratagene, La Jolla, California) using
a 59 primer that contains an SalI site immediately upstream
of the initiating methionine of the epitope tag and 39 primers
that contained novel stop codons followed by a BamHI site.
PCR products were digested with SalI and BamHI and
ligated into similarly digested pMSN1. The deletion mutant,
which removes 154 amino acids from the amino terminus,
was constructed by PCR using a 59 primer with an NcoI site
for cloning the PCR product into pMSN1 after the mAb
epitope tag. The internal deletion of amino acids 45–95 was
constructed by first subcloning the SalI/BamHI gene frag-
ment from pMSN1 into similarly digested pBK-CMV (Strat-
agene, La Jolla, California). Full-length linear DNA was
isolated after a partial DraI digestion, subjected to complete
digestion with EcoRV, and religated. Clones with the correct
deletion were isolated, and the gene fragment was sub-
cloned back into SalI/BamHI-digested pMSN1.
The SFV N1R-HSV ICP0 RING fusion gene was con-
structed by PCR Gene Soeing (Vallejo et al., 1995). This
construct replaces amino acids 172–234 of the N1R pro-
tein with amino acids 116–171 of ICP0. Plasmid pSHZ
containing the HSV-1 ICP0 gene was generously pro-
vided by Dr. S. Rice (University of Alberta, Edmonton,
Alberta, Canada).
Site-directed mutagenesis experiments were per-
formed using the QuikChange Site-Directed Mutagene-
sis Kit (Stratagene). All constructs were confirmed by
DNA sequencing.
Assay of zinc binding by SFV N1R deletion proteins
Each of the carboxyl-terminal deletion genes were
cloned into pET19b (Novagen, Madison, Wisconsin) and
expressed in Escherichia coli BL21 (DE3)LysS as previ-
ously described (Upton et al., 1994). Full-length and mu-
tant N1R proteins were recovered as insoluble inclusion
bodies, solubilized in loading buffer, separated on 12%
SDS-PAGE, electroblotted to nitrocellulose, and probed
with 65ZnCl2 as described previously (Upton et al., 1994).
Immunofluorescence and confocal microscopy
analysis
Cell cultures were grown in eight-chamber slides (Su-
perCell, Fisher Scientific, Pittsburgh, Pennsylvania), in-
fected with VV strain WR (m.o.i. 5 5), and transfected
(LipofectAce, GIBCO BRL) with 10 mg of vector purified
on QIAGEN columns (Chatsworth, California) at 2 h p.i.
After 18 h, cells were fixed (4% paraformaldehyde in PBS)
for 30 min at 4°C, and cells were then rinsed in PBS and
incubated with primary antibody (H1119) overnight. Prep-
arations were rinsed in PBS and incubated with FITC-
conjugated goat anti-mouse antibody (Biodesign Interna-
tional, Kennebunk, Maine) for 2 h at room temperature.
For DNA visualization, slides were also stained with
bisbenzimide Hoechst 33342 (Sigma Chemical, St. Louis,
Missouri) at 500 ng/ml in PBS for 30 min. After rinsing,
coverslips were mounted with Slow Fade (Molecular
Probes, Eugene, Oregon) and viewed with epifluores-
cence or with confocal laser scanning microscopy. Con-
focal images were collected on a Zeiss LSM 410 inverted
microscope. Series images were collected with 43 line
averaging, scanning at 8 s per frame; images were 512 3
512 pixels. Projections of series or portions of series
were used to make images. mAb H1119 cross-reacts
weakly with a host protein that appears to distribute
evenly within the plasma membrane. This cross-reactiv-
ity is not apparent in the confocal images because the
series of images chosen to make the figures did not
include those of the cell extremities. Untransfected cells
serve as negative controls for conventional epifluores-
cence microscopy (Fig. 5C, left).
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Construction of recombinant VV expressing the SFV
N1R protein
BGMK cells were infected with VV strain IHD-W (m.o.i.
5 2) followed by transfection of plasmid pMSN1 at 2 h
p.i. After 48 h, virus was harvested, and TK2 recombinant
VV-N1R was selected by two rounds of growth with
5-bromodeoxyuridine and plaque purified three times
using agarose overlays with screening for expression of
b-galactosidase. Expression of the epitope-tagged SFV
N1R protein was confirmed by Western blot analysis of
infected cell lysates using mAb H1119.
Isolation and solubilization of N1R-containing extracts
BGMK cells (108) were infected with the recombinant
VV-N1R (m.o.i. 5 3). After 4 h, the infected cells were
transferred to 30°C in an attempt to promote correct folding
of the recombinant protein and harvested 24 h p.i. Briefly,
cells were trypsinized in standard saline citrate (150 mM
NaCl, 15 mM Na citrate, pH 7.2), recovered by centrifugation
(2000 g, 5 min), washed twice in PBS, resuspended in a
hypotonic swelling buffer (10 mM Tris, pH 8.0, 2 mM MgCl2)
and lysed using a Dounce homogenizer. After centrifuga-
tion (800 g, 5 min), the N1R protein was extracted from the
pellet using a high salt buffer (50 mM Tris–HCl, pH 8.0, 0.6
M NaCl, 3 mM 2-mercaptoethanol, 1 mM EDTA, 10 mM
ZnCl2, 1 mM phenylmethylsulfonyl fluoride) for 30 min on
ice. Soluble N1R was recovered in the supernatant after
centrifugation (2500 g, 15 min). For DNA cellulose chroma-
tography, the soluble N1R extract was desalted using a
10-ml KwikSep polyacrylamide 6000 desalting column
(Pierce Chemical, Rockford, Illinois) into buffer 1 (50 mM
Tris–HCl, pH 8.0, 50 mM NaCl, 3 mM 2-mercaptoethanol, 1
mM phenylmethylsulfonyl fluoride).
DNA cellulose chromatography
dsDNA and ssDNA cellulose (Pharmacia Biotech, Pis-
cataway, New Jersey) was prepared in buffer 1. Protein
samples in the same buffer were applied to 1-ml col-
umns at a flow rate of 1 ml/h and recycled twice through
the column. The columns were washed with 6 ml of
buffer 1 and then eluted stepwise with buffer 1 contain-
ing 0.1, 0.25, 0.5, 0.75, 1.0, and 1.5 M NaCl. Samples were
analyzed by Western blotting after SDS-PAGE and elec-
troblotting to nitrocellulose.
Apoptotic DNA isolation and analysis
For the DNA fragmentation assays, samples of 106
BGMK cells, at 80% confluence, were infected with VV
(m.o.i. 5 3), infected with VV-N1R, mock infected, and
mock infected with no serum. Adherent and floating cells
were harvested at various times. Apoptotic DNA frag-
ments were recovered (Koyama and Miwa, 1997), sepa-
rated in a 1.5% agarose gel run at 2 V/cm for 12 h, and
visualized by UV after ethidium bromide staining.
For ELISA quantification of apoptosis, a sandwich as-
say was performed using a pair of mAbs specific for two
nucleosomal epitopes to capture and detect cytoplasmic
nucleosomes (Salgame et al., 1997). Hybridoma cell lines
(LG11–2 and PL2–3) were generously provided by Dr.
Marc Monestier (Temple University School of Medicine,
Philadelphia, Pennsylvania). mAbs were prepared by Im-
muno-Precise Antibodies (Victoria, British Columbia,
Canada). VV infections of BGMK cells were performed as
described for the DNA fragmentation assays, and cyclo-
heximide was used at 200 mg/ml. The ELISA was per-
formed using 2.5 3 104 cell equivalents per well.
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